- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DexCom Inc (DXCM)
DexCom Inc stock price live, this page displays NASDAQ DXCM stock exchange data. View the DXCM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DexCom Inc real time stock price chart below.
What Is the DexCom Inc Stock Price Today?
The DexCom Inc stock price today is 70.68.
What Is the Stock Symbol for DexCom Inc?
The stock symbol for DexCom Inc is "DXCM."
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXCM quote. (ISIN: US2521311074)
What Is the DexCom Inc Stock Price Today?
The DexCom Inc stock price today is 70.68.
What Is the Stock Symbol for DexCom Inc?
The stock symbol for DexCom Inc is "DXCM."
What Stock Exchange Does DexCom Inc Trade On?
DexCom Inc is listed and trades on the NASDAQ stock exchange.
Is DexCom Inc a Good Stock to Buy?
Determining whether DexCom Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXCM quote. (ISIN: US2521311074)
70.68
+5.60(+8.60%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.86
71.25
52 wk Range
54.11
93.25
DXCM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.8671.25
52 wk Range
54.1193.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DXCM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
85.19
Upside
+20.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro - DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro - DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro - DexCom receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
DexCom Inc Company Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DexCom Inc SWOT Analysis
CGM Market Leade | Explore DexCom's dominance in Continuous Glucose Monitoring, with $4.15 billion in revenue and a 24% return on equity, showcasing its strong market position. |
Financial Resilience | Delve into DexCom's robust financial performance, including a 14% year-over-year sales increase and projected revenue of $4.6 billion for 2025. |
Innovation Pipeline | Learn about DexCom's game-changing G7 15-Day CGM system and strategic partnerships, positioning the company for future growth in diabetes management. |
Growth Trajectory | Discover DexCom's expansion strategies, including Type 2 diabetes market penetration and international growth, with analyst price targets ranging from $93 to $103. |
DexCom Inc Earnings Call Summary for Q4/2025
- Dexcom exceeded Q4 2025 forecasts with EPS of $0.68 (vs $0.65) and revenue of $1.26B (vs $1.24B), yet stock fell 4.45% in after-hours trading to $68.15.
- Worldwide revenue grew 13% YoY, with international markets surging 18%, driven by strong demand for CGM systems and the launch of the Dexcom G7 15-day system.
- Financial highlights include gross profit of $799.8M (63.5% of revenue), operating income of $331.5M (26.3% of revenue), and cash reserves of approximately $2B.
- For 2026, Dexcom projects revenue between $5.16B-$5.25B (11-13% growth), with gross margin of 63-64% and operating margin of 22-23%.
- CEO Jake Leach emphasized the 'massive opportunity to improve metabolic health globally' and anticipates Medicare coverage expansion for new patient segments.
Last Updated: 13/02/2026, 09:48 am
Read Full TranscriptCompare DXCM to Peers and Sector
Metrics to compare | DXCM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDXCMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 37.9x | 9.7x | −0.5x | |
PEG Ratio | 4.59 | 0.02 | 0.00 | |
Price/Book | 10.0x | 3.7x | 2.6x | |
Price / LTM Sales | 6.0x | 2.6x | 3.3x | |
Upside (Analyst Target) | 29.2% | 49.8% | 46.6% | |
Fair Value Upside | Unlock | −0.3% | 6.4% | Unlock |
Analyst Ratings
25 Buy
3 Hold
1 Sell
Ratings:
29 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 85.19
(+20.53% Upside)
Earnings
Latest Release
Feb 12, 2026
EPS / Forecast
0.68 / 0.65
Revenue / Forecast
1.26B / 1.24B
People Also Watch
FAQ
What Is the DexCom (DXCM) Stock Price Today?
The DexCom stock price today is 70.68
What Stock Exchange Does DexCom Trade On?
DexCom is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for DexCom?
The stock symbol for DexCom is "DXCM."
What Is the DexCom Market Cap?
As of today, DexCom market cap is 27.00B.
What Is DexCom's Earnings Per Share (TTM)?
The DexCom EPS (TTM) is 1.80.
When Is the Next DexCom Earnings Date?
DexCom will release its next earnings report on 23/04/2026.
From a Technical Analysis Perspective, Is DXCM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has DexCom Stock Split?
DexCom has split 1 times.
How Many Employees Does DexCom Have?
DexCom has 10250 employees.
What is the current trading status of DexCom (DXCM)?
As of 13 Feb 2026, DexCom (DXCM) is trading at a price of 70.68, with a previous close of 65.08. The stock has fluctuated within a day range of 62.86 to 71.25, while its 52-week range spans from 54.11 to 93.25.
What Is DexCom (DXCM) Price Target According to Analysts?
The average 12-month price target for DexCom is USD85.19, with a high estimate of USD112 and a low estimate of USD68. 25 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an +20.53% Upside potential.
What Is the DXCM Premarket Price?
DXCM's last pre-market stock price is 62.79. The pre-market share volume is 18,170.00, and the stock has decreased by -2.29, or -3.52%.
What Is the DXCM After Hours Price?
DXCM's last after hours stock price is 64.21, the stock has decreased by -0.87, or -1.34%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.